Back
Actinium Pharmaceuticals Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
ATNM
Actinium Pharmaceuticals
Last Price:
$1.23
Seasonality Move:
5.17%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ATNM is experiencing slight selling pressure.
Actinium Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Buy |
| 20-day SMA: | 1.15 | Buy |
| 50-day SMA: | 1.21 | Buy |
| 200-day SMA: | 3 | Sell |
| 8-day EMA: | 1.17 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 2.71 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 56.75 | Buy |
| Chaikin Money Flow: | -25270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.2) | Buy |
| Bollinger Bands (100): | (1.12 - 1.62) | Sell |
Actinium Pharmaceuticals Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.23 while ATNM 8-day simple moving average is 1.16, which is a Buy signal.
-
The stock price of ATNM is 1.23 while Actinium Pharmaceuticals 20-day SMA is 1.15, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day simple moving average is 1.21 while ATNM share price is 1.23, making it a Buy technically.
-
ATNM stock price is 1.23 and Actinium Pharmaceuticals 200-day simple moving average is 3.00, creating a Sell signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
36
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a SellThe current Actinium Pharmaceuticals [ATNM] share price is $1.23. The Score for ATNM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
38.4M
Price in USD:
1.23
Share Volume:
124.9K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
10.24
52-Week Low:
1.03
Sell
36
Actinium Pharmaceuticals (ATNM)
is a Sell
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?The Actinium Pharmaceuticals stock price is 1.23 USD today.
-
Will ATNM stock go up or go down?Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Actinium Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.23 while ATNM 8-day exponential moving average is 1.17, which is a Buy signal.
-
The stock price of ATNM is 1.23 while Actinium Pharmaceuticals 20-day EMA is 1.16, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day exponential moving average is 1.23 while ATNM share price is 1.23, making it a Sell technically.
-
ATNM stock price is 1.23 and Actinium Pharmaceuticals 200-day simple moving average is 2.71, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
-
ATNM Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Actinium Pharmaceuticals is a Sell
-
Actinium Pharmaceuticals Relative Strength Index (RSI) is 56.75, which suggest Actinium Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.1 - 1.2), which suggest Actinium Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Actinium Pharmaceuticals is (1.12 - 1.62), which suggest Actinium Pharmaceuticals is a Sell
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.